![Ajanta Pharma increases on USFDA approval for Topiramate capsules. Ajanta Pharma](https://stockeasynow.com/wp-content/uploads/2023/08/image-removebg-preview-600x400.png)
Ajanta Pharma increases on USFDA approval for Topiramate capsules.
The share reached a 52-week high of Rs 1,804.70 on August 17, 2023, and a 52-week low of Rs 1,115.15 on October 28, 2022, respectively.-Ajanta Pharma Ajanta Pharma shares experienced a 1 percent increase to Rs 1,748.90 in the early trade on August 31 following the USFDA approval of its Topiramate extended release capsules. The…